R&D Pipeline

Pipeline (2021-2030)

Respiratory - Other-Bio. (1)

Modality Indication Targets Stage Company Project No. Detail
1
Other-Bio. Bronchopulmonary Dysplasia(BPD) Ago2 Lead Samsung Medical Center HN22C0414